Circadian changes in the hemostatic system in healthy men and patients with cardiovascular diseases

Piotr Chrusciel1, Aleksander Goch, Maciej Banach

  • 1Department of Cardiology and Cardiac Surgery, Military University Hospital No. 10 with a Polyclinic in Bydgoszcz, Bydgoszcz, Poland.

Insights

Circadian rhythms significantly impact hemostasis, increasing cardiovascular event risk in the morning. These daily variations in blood clotting factors and platelet activity are crucial for understanding morning heart attack and stroke incidence.

Area of Science:

  • Circadian Biology
  • Hemostasis and Thrombosis
  • Cardiovascular Medicine

Background:

  • Cardiovascular events exhibit a pronounced morning peak, potentially linked to circadian variations in hemostasis.
  • Daily fluctuations in von Willebrand factor (vWF), platelet count, and platelet aggregability are observed.
  • Coagulation and fibrinolysis markers show distinct 24-hour patterns, influencing morning cardiovascular risk.

Purpose of the Study:

  • To review the circadian rhythms of key hemostatic components.
  • To explore the relationship between daily hemostatic changes and the morning incidence of cardiovascular events.
  • To highlight alterations in circadian hemostasis patterns in individuals with health issues.

Main Methods:

  • Systematic review of existing literature on circadian variations in hemostasis.
  • Analysis of 24-hour periodicity in endothelium, platelets, coagulation, and fibrinolysis.
  • Comparison of circadian hemostatic patterns in healthy subjects versus those with health problems.

Main Results:

  • Circadian variability noted in vWF, platelet number (peak afternoon), and platelet aggregability (peak morning).
  • Elevated morning levels of coagulation markers (fragment 1+2, factor VIIa, fibrinogen) and PAI-1 activity.
  • Coagulation inhibitors (protein C, antithrombin III, TFPI) show peak activity in the morning; fibrinolytic activators lack periodicity.

Conclusions:

  • Circadian changes in the hemostatic system, particularly morning increases in prothrombotic factors, contribute to elevated cardiovascular event risk.
  • Disrupted circadian hemostasis patterns in unhealthy individuals may exacerbate cardiovascular risk.
  • Understanding these diurnal rhythms is vital for cardiovascular event prevention strategies.

Related Concept Videos

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...